In situ staining of matricellular proteins, such as FN, SPARC, and collagens, as well as IHC or immunofluorescence (IF) quantification of tumor-infiltrating lymphocytes and other immune cells (13–17) provided results partially in line with GEP, but highly controversial due to their low reproducibility and questionable validation. This evidence concerns the gene SPARC and neoplasm.